Acta clinica Croatica, Vol. 56. No. 2., 2017.
Izvorni znanstveni članak
Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients
; Department of Virology, Croatian Institute of Public Health; School of Medicine, University of Zagreb
Branko Kolarić ; Department of Epidemiology, Andrija Štampar Teaching Institute of Public Health, Zagreb; School of Medicine, University of Rijeka, Rijeka
Maja Bogdanić ; Department of Virology, Croatian Institute of Public Health
Irena Tabain ; Department of Virology, Croatian Institute of Public Health
Nataša Beader ; School of Medicine, University of Zagreb; Zagreb University Hospital Centre, Zagreb, Croatia
Puni tekst: engleski pdf 94 Kb
APA 6th Edition
Vilibić-Čavlek, T., Kolarić, B., Bogdanić, M., Tabain, I. i Beader, N. (2017). Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients. Acta clinica Croatica, 56. (2.), 255-261. https://doi.org/10.20471/acc.2017.56.02.08
MLA 8th Edition
Vilibić-Čavlek, Tatjana, et al. "Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients." Acta clinica Croatica, vol. 56., br. 2., 2017, str. 255-261. https://doi.org/10.20471/acc.2017.56.02.08. Citirano 24.03.2023.
Chicago 17th Edition
Vilibić-Čavlek, Tatjana, Branko Kolarić, Maja Bogdanić, Irena Tabain i Nataša Beader. "Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients." Acta clinica Croatica 56., br. 2. (2017): 255-261. https://doi.org/10.20471/acc.2017.56.02.08
Vilibić-Čavlek, T., et al. (2017). 'Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients', Acta clinica Croatica, 56.(2.), str. 255-261. https://doi.org/10.20471/acc.2017.56.02.08
Vilibić-Čavlek T, Kolarić B, Bogdanić M, Tabain I, Beader N. Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients. Acta clinica Croatica [Internet]. 2017 [pristupljeno 24.03.2023.];56.(2.):255-261. https://doi.org/10.20471/acc.2017.56.02.08
T. Vilibić-Čavlek, B. Kolarić, M. Bogdanić, I. Tabain i N. Beader, "Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients", Acta clinica Croatica, vol.56., br. 2., str. 255-261, 2017. [Online]. https://doi.org/10.20471/acc.2017.56.02.08
Herpes group viruses (herpes simplex virus, HSV; varicella-zoster virus, VZV; cytomegalovirus, CMV; and Epstein-Barr virus, EBV) remain an important cause of morbidity in immunocompromised persons. The aim of the study was to analyze the prevalence of HSV-1, HSV-2, VZV, CMV and EBV in patients undergoing hemodialysis. During a three-year period (2013-2015), 152 consecutive serum samples from hemodialysis patients and 150 healthy subjects (control group) were tested for the presence of IgM/IgG antibodies to herpes group viruses. Serologic tests were performed using a commercial enzyme-linked immunosorbent assay (ELISA) or enzyme-linked immunofluorescent assay (ELFA). Hemodialysis patients showed significantly higher CMV IgG seropositivity compared to controls (88.2% vs. 78.7%, p=0.011). In addition, seroprevalence rates of HSV-1 and VZV were higher in hemodialysis patients; however, these differences did not reach statistical significance (85.5% vs. 80.0%, p=0.054 and 99.3% vs. 96.0%, p=0.051, respectively). The prevalence of HSV-2 and EBV was similar in both groups (12.5% vs. 12.7%, p=0.137 and 98.0% vs. 95.3%, p=0.113, respectively). There was no difference in IgG seropositivity according to gender and place of residence. Logistic regression showed that older age was a significant predictor for CMV and EBV IgG seropositivity (increase in age by one year: CMV OR=1.055; 95%CI=1.030-1.080 and EBV OR=1.075, 95%CI=1.023-1.130).
Herpesvirus 1, human, Herpesvirus 3, human, Cytomegalovirus, herpesvirus 4, human, Renal dialysis, Croatia
Posjeta: 1.684 *